Document is current
Any future updates will be listed below
-
Authors
Rendo, Veronica https://orcid.org/0000-0002-2983-4020
Schubert, Michael https://orcid.org/0000-0002-6862-5221
Khuu, Nicholas https://orcid.org/0009-0001-9967-1538
Suarez Peredo Rodriguez, Maria F.
Whyte, Declan
Ling, Xiao
van den Brink, Anouk https://orcid.org/0000-0003-1316-8673
Huang, Kaimeng https://orcid.org/0000-0002-0552-209X
Swift, Michelle https://orcid.org/0000-0003-3645-1308
He, Yizhou https://orcid.org/0000-0002-1396-7275
Zerbib, Johanna
Smith, Ross https://orcid.org/0000-0003-4239-3204
Raaijmakers, Jonne
Bandopadhayay, Pratiti https://orcid.org/0000-0002-4175-4760
Guenther, Lillian M. https://orcid.org/0000-0002-5906-7504
Hwang, Justin H.
Iniguez, Amanda
Moody, Susan
Seo, Ji-Heui
Stover, Elizabeth H. https://orcid.org/0000-0002-6578-3216
Garraway, Levi
Hahn, William C. https://orcid.org/0000-0003-2840-9791
Stegmaier, Kimberly https://orcid.org/0000-0003-0218-7895
Medema, René H. https://orcid.org/0000-0002-6754-0381
Chowdhury, Dipanjan https://orcid.org/0000-0001-5645-3752
Colomé-Tatché, Maria
Ben-David, Uri https://orcid.org/0000-0001-7098-2378
Beroukhim, Rameen https://orcid.org/0000-0001-6303-3609
Foijer, Floris https://orcid.org/0000-0003-0989-3127
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 8 January 2025
First Online: 27 January 2025
Competing interests
: K.S. is on the SAB and has stock options with Auron Therapeutics. K.S. receives grant funding from Novartis and KronosBio on topics unrelated to this manuscript. W.C.H. is a consultant for Thermo Fischer Scientific, Solasta Ventures, MPM capital, KSQ Therapeutics, Tyra Biosciences, Frontier Medicines, Jubilant Therapeutics, RAPPTA Therapeutics, Serinus Biosciences, Hexagon Biosciences, Kestral Therapeutics, Function Oncology, and Calyx. R.B. consults for Scorpion Therapeutics and receives grant funding from Novartis. U.B.D. consults for Accenet Therapeutics and received funding from Novocure. F.F. is co-founder and Chief Scientific Officer of iPsomics. The work in this study is unrelated to this role. The remaining authors declare no competing interests.
